Posted on October 31st, 2008 by Health News
A research study carried out by the Universidad Complutense de Madrid (UCM) proves that administering natural antioxidants can reduce the effects of lead poisoning in animals during the gestation and lactation periods. The study suggests that it could also be effective in humans.
No Comments »
Filed under: General Health News
Posted on October 31st, 2008 by Health News
More than 35 million people in Bangladesh, around a quarter of its population, face acute poverty and hunger. Dowry payments of more than 200 times the daily wage and costly medical expenses are major causes of this chronic poverty says research from the University of Bath.
No Comments »
Filed under: Women's Health
Posted on October 31st, 2008 by Health News
(World Journal of Gastroenterology) To evaluate esophageal transit time of subjects in three anatomical inclinations and to compare the mean values obtained from measurement in these positions. authors used a biomagnetic modality that measured the transit time of a magnetic marker through the esophagus in 14 healthy subjects. They demonstrated that using this method, it [...]
No Comments »
Filed under: General Health News
Posted on October 31st, 2008 by Health News
(World Journal of Gastroenterology) Computed tomography perfusion is a noninvasive technique for assessing perfusion changes due to transarterial chemoembolization for advanced HCC. In this study, the changes found in CT perfusion parameters in viable tumors were correlated to different responses of hepatocellular carcinoma to TACE. Therefore, CT perfusion imaging is a feasible technique for monitoring [...]
No Comments »
Filed under: General Health News
Posted on October 31st, 2008 by Health News
(University of Western Ontario) Significant increases in surgical capacity or diverting patients to other jurisdictions are the best ways to deal with excessive wait times for hip and knee replacement surgery — a leading symbol of underfunding in Canada’s health-care system. Politically popular strategies, such as wait time guarantees, are not likely [...]
No Comments »
Filed under: General Health News
Posted on October 31st, 2008 by Health News
(World Journal of Gastroenterology) Chronic cholestasic liver diseases lead to liver injury and ultimately progress to portal fibrosis, cirrhosis, and end-stage liver disease requiring liver transplantation. A research group in the US and Germany investigated the effects of (dietary) glycine against oxidant-induced injury caused by bile duct ligation in rats. The study demonstrate that hepatic [...]
No Comments »
Filed under: General Health News
Posted on October 31st, 2008 by Health News
(World Journal of Gastroenterology) Inflammatory bowel disease comprises a group of chronic, lifelong, immuno-inflammatory disorders with the pivotal role of oxygen free radicals in the genesis of mucosal damage. This research investigated the effect of rectal administration of d-alpha tocopherol in relieving symptoms in patients with mild and moderate ulcerative colitis. In the study, d-alpha [...]
No Comments »
Filed under: General Health News
Posted on October 31st, 2008 by Health News
You couldn’t ignore the news if you tried. The economic crisis is all over magazines, newspapers and television news programs. So, it’s no wonder people are feeling anxious and stressed out. But women may be reacting more strongly than men. A recent survey from the American Psychological Association (APA) called “Stress in America” [...]
No Comments »
Filed under: Women's Health
Posted on October 31st, 2008 by Health News
UCB has announced pivotal RAPID 1 (RA PreventIon of structural Damage) data published in Arthritis & Rheumatism shows CIMZIA (certolizumab pegol), the only PEGylated anti-TNF (Tumour Necrosis Factor alpha), together with methotrexate (MTX), rapidly reduced symptoms of disease and inhibited progression of joint damage in adult patients with active rheumatoid arthritis (RA), with sustained results [...]
No Comments »
Filed under: Pharmacy News
Posted on October 31st, 2008 by Health News
GlaxoSmithKline today issued the following response to a petition filed by Public Citizen to the U.S. Food and Drug Administration (FDA) on Avandia (rosiglitazone maleate), a highly effective therapy for treating type 2 diabetes when used in the appropriate patient population.
No Comments »
Filed under: Pharmacy News